Genmab
Roberto Spreafico has a diverse background in bioinformatics and immunology. With experience in companies like Genmab and Absci, Roberto has led AI-assisted drug discovery programs and managed teams of scientists. Roberto has also worked on projects related to chronic viral infections, bioinformatics, and genome engineering. Roberto's educational background includes a PhD in Translational and Molecular Medicine from Università degli Studi di Milano-Bicocca.
This person is not in any offices
Genmab
42 followers
Genmab is a publicly traded, international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer.